These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 23526406)
21. Rac-GTPase, osteoclast cytoskeleton and bone resorption. Razzouk S; Lieberherr M; Cournot G Eur J Cell Biol; 1999 Apr; 78(4):249-55. PubMed ID: 10350213 [TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts. Nakamura I; Jimi E; Duong LT; Sasaki T; Takahashi N; Rodan GA; Suda T J Biol Chem; 1998 May; 273(18):11144-9. PubMed ID: 9556601 [TBL] [Abstract][Full Text] [Related]
23. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Tanaka S; Amling M; Neff L; Peyman A; Uhlmann E; Levy JB; Baron R Nature; 1996 Oct; 383(6600):528-31. PubMed ID: 8849724 [TBL] [Abstract][Full Text] [Related]
25. Role of CrkII Signaling in RANKL-Induced Osteoclast Differentiation and Function. Kim JH; Kim K; Kim I; Seong S; Nam KI; Lee SH; Kim KK; Kim N J Immunol; 2016 Feb; 196(3):1123-31. PubMed ID: 26695370 [TBL] [Abstract][Full Text] [Related]
26. Cyclophilin A (CypA) Plays Dual Roles in Regulation of Bone Anabolism and Resorption. Guo M; James AW; Kwak JH; Shen J; Yokoyama KK; Ting K; Soo CB; Chiu RH Sci Rep; 2016 Mar; 6():22378. PubMed ID: 26932182 [TBL] [Abstract][Full Text] [Related]
27. The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas. Roselli S; Wallez Y; Wang L; Vervoort V; Pasquale EB Cell Signal; 2010 Nov; 22(11):1745-52. PubMed ID: 20603213 [TBL] [Abstract][Full Text] [Related]
28. Rho-GEF trio regulates osteoclast differentiation and function by Rac1/Cdc42. Gu J; Yang Z; Yuan L; Guo S; Wang D; Zhao N; Meng L; Liu H; Chen W; Ma J Exp Cell Res; 2020 Nov; 396(1):112265. PubMed ID: 32898553 [TBL] [Abstract][Full Text] [Related]
30. Critical role of cortactin in actin ring formation and osteoclastic bone resorption. Matsubara T; Myoui A; Ikeda F; Hata K; Yoshikawa H; Nishimura R; Yoneda T J Bone Miner Metab; 2006; 24(5):368-72. PubMed ID: 16937268 [TBL] [Abstract][Full Text] [Related]
31. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro. Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660 [TBL] [Abstract][Full Text] [Related]
33. VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Yang Q; McHugh KP; Patntirapong S; Gu X; Wunderlich L; Hauschka PV Matrix Biol; 2008 Sep; 27(7):589-99. PubMed ID: 18640270 [TBL] [Abstract][Full Text] [Related]
34. p130Cas, Crk-associated substrate plays essential roles in liver development by regulating sinusoidal endothelial cell fenestration. Tazaki T; Sasaki T; Uto K; Yamasaki N; Tashiro S; Sakai R; Tanaka M; Oda H; Honda Z; Honda H Hepatology; 2010 Sep; 52(3):1089-99. PubMed ID: 20623582 [TBL] [Abstract][Full Text] [Related]
35. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice. Gil-Henn H; Destaing O; Sims NA; Aoki K; Alles N; Neff L; Sanjay A; Bruzzaniti A; De Camilli P; Baron R; Schlessinger J J Cell Biol; 2007 Sep; 178(6):1053-64. PubMed ID: 17846174 [TBL] [Abstract][Full Text] [Related]
36. Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading. Lakkakorpi PT; Wesolowski G; Zimolo Z; Rodan GA; Rodan SB Exp Cell Res; 1997 Dec; 237(2):296-306. PubMed ID: 9434625 [TBL] [Abstract][Full Text] [Related]
37. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts. Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the bone phenotype in ClC-7-deficient mice. Neutzsky-Wulff AV; Karsdal MA; Henriksen K Calcif Tissue Int; 2008 Dec; 83(6):425-37. PubMed ID: 18958510 [TBL] [Abstract][Full Text] [Related]
39. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention. Kupisiewicz K Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989 [TBL] [Abstract][Full Text] [Related]
40. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption. Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]